日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Prioritising the Burden of Geographic Atrophy and Treatment Expectations: A Modified Nominal Group Technique Study with International Patient-Led Organisations

优先考虑地图状萎缩的负担和治疗期望:一项采用改良名义小组技术与国际患者主导组织合作的研究

Paudel, Nabin; Moran, Ellen M; Stafford, Sinead; McVicker, Kelly; Stratieva, Petia; Daly, Avril

D(LCO) Biologic Quality-Control Findings From a Multi-Center Global Study

来自一项多中心全球研究的D(LCO)生物制品质量控制结果

Becker, Ellen A; Moran, Ellen M; Blonshine, Jason B; Blonshine, Susan B

Airborne Particulate Concentrations During and After Pulmonary Function Testing

肺功能测试期间及之后空气中颗粒物浓度

Li, Jie; Jing, Guoqiang; Fink, James B; Porszasz, Janos; Moran, Ellen M; Kiourkas, Renee D; McLaughlin, Roisin; Vines, David L; Dhand, Rajiv

Antiviral drug allergy

抗病毒药物过敏

Milpied-Homsi, Brigitte; Moran, Ellen M; Phillips, Elizabeth J

Human rheumatoid arthritis tissue production of IL-17A drives matrix and cartilage degradation: synergy with tumour necrosis factor-alpha, Oncostatin M and response to biologic therapies.

人类类风湿性关节炎组织产生的 IL-17A 驱动基质和软骨降解:与肿瘤坏死因子-α、抑癌素 M 的协同作用以及对生物疗法的反应

Moran Ellen M, Mullan Ronan, McCormick Jennifer, Connolly Mary, Sullivan Owen, Fitzgerald Oliver, Bresnihan Barry, Veale Douglas J, Fearon Ursula